Insider Move: R. Dirk Allison Exercises Options, Realizing $2.36M At Addus HomeCare - Addus HomeCare ( NASDAQ:ADUS )
On August 21, it was revealed in an SEC filing that R. Dirk Allison, Chairman and CEO at Addus HomeCare ADUS executed a significant exercise of company stock options.
Addus HomeCare ( ADUS ) Q2 Revenue Up 22%
Addus HomeCare ( NASDAQ:ADUS ) , a leading provider of home-based personal care, hospice, and home health services, reported its second quarter 2025 financial results on August 4, 2025. The company posted revenue ( GAAP ) and earnings per share ( non-GAAP ) figures that exceeded Wall Street ...
Addus HomeCare ( ADUS ) Surpasses Q2 Earnings and Revenue Estimates
Addus HomeCare (ADUS) delivered earnings and revenue surprises of +2.76% and +0.40%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Amedisys ( AMED ) Beats Q2 Earnings and Revenue Estimates
Amedisys (AMED) delivered earnings and revenue surprises of +10.79% and +2.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Brookdale's Occupancy Registers a Rise to 80.5% in June 2025
BKD's June occupancy improves 230 bps year over year to 80.5%, driven by stronger move-ins and move-out activity across its senior living communities.
ADUS vs. USPH: Which Stock Should Value Investors Buy Now?
ADUS vs. USPH: Which Stock Is the Better Value Option?
Do Options Traders Know Something About Addus HomeCare Stock We Don't?
Investors need to pay close attention to ADUS stock based on the movements in the options market lately.
Home Health Braces For Potential $1 Billion Cut In Medicare Payments - Addus HomeCare ( NASDAQ:ADUS )
CMS proposes a 6.4% drop in Medicare payments to home health agencies in 2026, totaling a $1.135 billion reduction. Amedisys earns 63% of revenue from home health; Addus sees 5%, with a focus on nonmedical care. Geopolitical tensions, Fed uncertainty, and fast-moving headlines are driving July ...
BTSG Raises 2025 Financial Outlook: What's Backing It?
BrightSpring boosts 2025 guidance as Pharmacy and Provider segments post strong gains and margin initiatives take hold.
BrightSpring's Home Health Arm Soars: What's Powering Growth?
BTSG's Home Health Care Q1 2025 sales surge 21%, fueled by Medicare Advantage gains and high patient satisfaction.
BrightSpring's Care Ratings Climb: Is Its Lead Sustainable?
BTSG boosts care quality with tech upgrades, earning top ratings and patient satisfaction across all segments.
Implied Volatility Surging for Addus HomeCare Stock Options
Investors need to pay close attention to ADUS stock based on the movements in the options market lately.
Addus HomeCare ( ADUS ) Beats Q1 Earnings Estimates
Addus HomeCare (ADUS) delivered earnings and revenue surprises of 6.77% and 0.68%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Elanco Animal Health Incorporated ( ELAN ) Q1 Earnings Expected to Decline
Elanco Animal Health (ELAN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Humana Beat Q1 Earnings Estimates on Growing Premiums?
HUM's first-quarter results are likely to benefit from higher Medicare stand-alone PDP revenues.
ADUS or USPH: Which Is the Better Value Stock Right Now?
ADUS vs. USPH: Which Stock Is the Better Value Option?
Addus HomeCare ( ADUS ) Earnings Expected to Grow: Should You Buy?
Addus HomeCare (ADUS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HCA Healthcare Q1 Earnings Beat on Growing Patient Volumes
HCA continues to witness growth in reported and same-facility admissions. The company reaffirms 2025 guidance.
Molina Healthcare Q1 Earnings Beat Estimates on Growing Premiums
MOH continues to expect 2025 premium revenues to be around $42 billion.
Elevance Health's Q1 Earnings Beat Estimates on Rising Premiums
ELV continues to witness significant growth in Q1 revenues. However, its operating costs surge.
CYH to Sell Stake in Cedar Park Regional to Ascension in $460M Deal
Community Health is set to divest an 80% ownership stake in Cedar Park Regional to Ascension Health.
Zacks Industry Outlook Highlights DaVita, Encompass Health, Option Care Health and Addus HomeCare
DaVita, Encompass Health, Option Care Health and Addus HomeCare have been highlighted in this Industry Outlook article.
Addus HomeCare ( ADUS ) Surges 4.9%: Is This an Indication of Further Gains?
Addus HomeCare (ADUS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
4 Stocks to Watch in a Dynamic Outpatient Home Health Industry
An aging global population and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DVA, EHC, OPCH and ADUS are well-poised to gain.
ADUS or USPH: Which Is the Better Value Stock Right Now?
ADUS vs. USPH: Which Stock Is the Better Value Option?
Addus HomeCare ( ADUS ) Upgraded to Strong Buy: Here's Why
Addus HomeCare (ADUS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
UnitedHealth's Optum Rx & EPN Team Up for Fairer Pharmacy Payments
UNH and EPN join forces to enhance pharmacy reimbursement, ensuring fair payments and better stability for independent pharmacies.
Humana's CenterWell Launches Gladstone Walmart Location for Seniors
The easy accessibility for patients will give HUM a competitive edge over other senior-focused healthcare providers.
Encompass Health Expands Partnership With Piedmont in Georgia
EHC and Piedmont expand their partnership with a new rehab hospital in Athens, enhancing patient recovery services.
Molina Healthcare Expands Presence With Illinois D-SNP Contract Win
MOH secures a key Illinois contract, strengthening its foothold in the dual-eligible market.
ADUS vs. USPH: Which Stock Is the Better Value Option?
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Addus HomeCare ( ADUS Quick QuoteADUS - ) and U.S. Physical Therapy ( USPH Quick QuoteUSPH - ) . But which of these two companies is the best option for those looking for undervalued stocks?
Humana & Icon Enhance Senior Healthcare With Integrated Specialty Care
HUM's CenterWell and Conviva partner with Icon Health, improving musculoskeletal care access for seniors.
Are Investors Undervaluing Addus HomeCare ( ADUS ) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Teladoc Expands Specialty Care Access With Carrum Health Partnership
TDOC partners with Carrum Health in a bid to expand access to specialty care.
Here's What Brookdale's Occupancy Growth Story Tells Us
BKD is likely to have witnessed 40 straight months of year-over-year increases in weighted average occupancy.
Teladoc Doubles Down on Connected Care With New Partnerships
With more than 93 million members, deeper integration of services could lead to higher utilization for TDOC.
Is the Options Market Predicting a Spike in Addus HomeCare ( ADUS ) Stock?
Investors need to pay close attention to Addus HomeCare (ADUS) stock based on the movements in the options market lately.
Here's Why Community Health's Florida Divestiture Matters
Offloading the Punta Gorda facility is expected to remove uncertainty tied to restoration costs and revenue losses for CYH.
ADUS or USPH: Which Is the Better Value Stock Right Now?
ADUS vs. USPH: Which Stock Is the Better Value Option?
Addus HomeCare ( ADUS ) Q4 Earnings Match Estimates
Addus HomeCare (ADUS) delivered earnings and revenue surprises of 0% and 1.71%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Down -16.38% in 4 Weeks, Here's Why You Should You Buy the Dip in Addus HomeCare ( ADUS )
Addus HomeCare (ADUS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
3 Reasons Why Growth Investors Shouldn't Overlook Addus HomeCare ( ADUS )
Addus HomeCare (ADUS) possesses solid growth attributes, which could help it handily outperform the market.
Should Value Investors Buy Addus HomeCare ( ADUS ) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Pick These 4 Stocks With Impressive Interest Coverage Ratios
DECK, BOOT, ADUS & ENSG's impressive interest coverage ratios highlight that these companies can withstand financial hardships.
Ahead of Addus HomeCare ( ADUS ) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for Addus HomeCare (ADUS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2024.
ADUS vs. CHE: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Addus HomeCare ( ADUS Quick QuoteADUS - ) and Chemed ( CHE Quick QuoteCHE - ) . But which of these two stocks is more attractive to value investors?
DVA Q4 Estimates Unchanged Before Earnings: How to Play the Stock?
Continued strength in RPT is likely to have boosted DaVita's top line in the fourth quarter despite supply challenges weighing on its performance.
ADUS or USPH: Which Is the Better Value Stock Right Now?
ADUS vs. USPH: Which Stock Is the Better Value Option?
Are Medical Stocks Lagging Addus HomeCare ( ADUS ) This Year?
Here is how Addus HomeCare (ADUS) and Arcutis Biotherapeutics, Inc. (ARQT) have performed compared to their sector so far this year.
Zacks Industry Outlook Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare
Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare have been highlighted in this Industry Outlook article.
